Amgen announces USD 650 million expansion of US manufacturing network
- 30 September 2025
- 1 month ago
Novartis commences tender offer to buy Tourmaline Bio
- 30 September 2025
- 1 month ago
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure
- 30 September 2025
- 1 month ago
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol
- 30 September 2025
- 1 month ago
JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis
- 30 September 2025
- 1 month ago
AstraZeneca to harmonise its listing structure across LSE, STO and NYSE
- 30 September 2025
- 1 month ago
GSK appoints Luke Miels as CEO designate
- 29 September 2025
- 1 month ago
Intas Pharma appoints Akash Kalal as General Manager - API Production
- 29 September 2025
- 1 month ago
Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact
- 29 September 2025
- 1 month ago
Recent News
GLP-1 Receptor Agonists Linked to Lower Risk of Ea...
- 03 November, 2025
Ketogenic diet may protect against stress experien...
- 03 November, 2025
STORM-PE Trial: Mechanical Thrombectomy Shows Supe...
- 03 November, 2025
AIIMS INI CET January 2026 admit cards released
- 03 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









